Paul M. Barr, M.D.

Paul M. Barr, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Journal Articles

Showing all 39 journal articles available.

2015 Oct 12
Holkova B, Kmieciak M, Bose P, Yazbeck VY, Barr PM, Tombes MB, Shrader E, Weir-Wiggins C, Rollins AD, Cebula EM, Pierce E, Herr M, Sankala H, Hogan KT, Wan W, Feng C, Peterson DR, Fisher RI, Grant S, Friedberg JW. "Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas." Leukemia & lymphoma. 2015 Oct 12; :1-9. Epub 2015 Oct 12.
2015 Aug
Wilson WH, Young RM, Schmitz R, Yang Y, Pittaluga S, Wright G, Lih CJ, Williams PM, Shaffer AL, Gerecitano J, de Vos S, Goy A, Kenkre VP, Barr PM, Blum KA, Shustov A, Advani R, Fowler NH, Vose JM, Elstrom RL, Habermann TM, Barrientos JC, McGreivy J, Fardis M, Chang BY, Clow F, Munneke B, Moussa D, Beaupre DM, Staudt LM. "Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma." Nature medicine. 2015 Aug; 21(8):922-6. Epub 2015 Jul 20.
2015 Jul 20
Barr PM, Li H, Spier C, Mahadevan D, LeBlanc M, Ul Haq M, Huber BD, Flowers CR, Wagner-Johnston ND, Horwitz SM, Fisher RI, Cheson BD, Smith SM, Kahl BS, Bartlett NL, Friedberg JW. "Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Jul 20; 33(21):2399-404. Epub 2015 Jun 15.
2015 May 7
Brown JR, Barrientos JC, Barr PM, Flinn IW, Burger JA, Tran A, Clow F, James DF, Graef T, Friedberg JW, Rai K, O'Brien S. "The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia." Blood. 2015 May 7; 125(19):2915-22. Epub 2015 Mar 09.
2015 Mar
Barr PM. "Rituximab maintenance in follicular lymphoma." Clinical advances in hematology & oncology : H&O. 2015 Mar; 13(3):158-61.
2015 Feb
Hutchinson K, Jahangiri S, Calvi LM, Barr P, Friedberg JW, Kelly JL. "Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma." Leukemia & lymphoma. 2015 Feb; 56(2):508-11. Epub 2014 Jul 15.
2014 Sep
Jahangiri S, Barr P, Friedberg J. "Emerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma." Expert opinion on emerging drugs. 2014 Sep; 19(3):367-83. Epub 2014 Jun 24.
2014 Aug 21
Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. "Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma." Blood. 2014 Aug 21; 124(8):1259-65. Epub 2014 Jul 11.
2014 Aug
Barr PM. "Maintenance rituximab should be considered for patients with follicular lymphoma." Clinical advances in hematology & oncology : H&O. 2014 Aug; 12(8):541-3.
2014 Jul 17
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, Schuh A, de Vos S, Gill D, Bloor A, Dearden C, Moreno C, Jones JJ, Chu AD, Fardis M, McGreivy J, Clow F, James DF, Hillmen P, . "Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia." The New England journal of medicine. 2014 Jul 17; 371(3):213-23. Epub 2014 May 31.
2014 Jul
Evens AM, Carson KR, Kolesar J, Nabhan C, Helenowski I, Islam N, Jovanovic B, Barr PM, Caimi PF, Gregory SA, Gordon LI. "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Jul; 25(7):1449.
2014 Jun
Barr PM, Zent CS. "The ABC of chronic lymphocytic leukemia: etiology of cytopenias is important in staging and management." Leukemia & lymphoma. 2014 Jun; 55(6):1219-20. Epub 2013 Nov 01.
2014 Mar 1
Cleary JM, Rodig S, Barr PM, Shinagare AB, Clark JW, Shapiro GI, Armand P. "Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma." Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Mar 1; 12(3):323-6; quiz 326.
Barr PM, Zent CS. "Infection in chronic lymphocytic leukemia: parsimony has its limits." Leukemia & lymphoma. 2014 55(12):2683-4. Epub 2014 May 16.
2013 Oct
Barr PM. "Flavopiridol: Judged by the company one keeps." Leukemia research. 2013 Oct; 37(10):1187-8. Epub 2013 Jul 08.
2013 Aug
Herman SE, Barr PM, McAuley EM, Liu D, Wiestner A, Friedberg JW. "Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia." Leukemia. 2013 Aug; 27(8):1769-73. Epub 2013 Feb 06.
2013 Feb
Barr PM. "Fffuse large B-cell lymphoma in the very elderly: the case for refining our clinical trials." Oncology. 2013 Feb; 27(2):140, 142.
Evens AM, Carson KR, Kolesar J, Nabhan C, Helenowski I, Islam N, Jovanovic B, Barr PM, Caimi PF, Gregory SA, Gordon LI. "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology. 2013 24(12):3076-81. Epub 2013 Oct 20.
2012 Jul
Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, Margevicius S, Fu P, van Heeckeren W, Lazarus HM, Cooper BW, Gerson SL, Barr P, Tse WW, Curtis C, Fanning LR, Creger RJ, Carlson-Barko JM, Laughlin MJ. "Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies." Bone marrow transplantation. 2012 Jul; 47(7):924-33. Epub 2011 Oct 17.
2012 Jun
Noel MS, Friedberg JW, Barr PM. "Novel agents in mantle cell lymphoma." Best practice & research. Clinical haematology. 2012 Jun; 25(2):191-200. Epub 2012 Apr 30.
2012 Mar
Barr PM, Wei C, Roger J, Schaefer-Cutillo J, Kelly JL, Rosenberg AF, Jung J, Sanz I, Friedberg JW. "Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion." Clinical immunology : the official journal of the Clinical Immunology Society. 2012 Mar; 142(3):237-42. Epub 2012 Jan 05.
Caimi PF, Barr PM, Berger NA, Lazarus HM. "Non-Hodgkin's Lymphoma in the Elderly". Drugs & Aging. 2012; 27(3): 211-238.
Noel, MS; Friedberg, JW; Barr, PM;. "Novel agents in mantle cell lymphoma". Best Practices & Resaerch Clinical Haematology. 2012; 25(2): 191-200.
Bayraktar UD, Ramos JC, Petrich A, Gupta N, Lensing S, Moore P, Reid EG, Aboulafia DM, Ratner L, Mitsuyasu R, Cooley T, Henry DH, Barr P, Noy A. "Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium." Leukemia & lymphoma. 2012 53(12):2383-9. Epub 2012 Jul 09.
2011 Nov
Carter SJ, Bernstein SH, Friedberg JW, Barr PM. "Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma." Leukemia research. 2011 Nov; 35(11):e223-4. Epub 2011 Aug 06.
2011 Jul
Lazarus HM, Sommers SR, Arfons LM, Fu P, Ataergin SA, Kaye NM, Liu F, Kindwall-Keller TL, Cooper BW, Laughlin MJ, Creger RJ, Barr PM, Gerson SL, Kaplan D. "Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Jul; 17(7):970-8. Epub 2011 Apr 11.
2011 Jul
Barr PM, Friedberg JW. "Getting to the heart of the problem in treating diffuse large B-cell lymphoma." Leukemia & lymphoma. 2011 Jul; 52(7):1166-7. Epub 2011 May 25.
2011 Jun
Dao H, Barr PM, Honda K. "Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox." Journal of the American Academy of Dermatology. 2011 Jun; 64(6):e123-5.
2010 Sep
Harr MW, Caimi PF, McColl KS, Zhong F, Patel SN, Barr PM, Distelhorst CW. "Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia." Cell death and differentiation. 2010 Sep; 17(9):1381-91. Epub 2010 Mar 19.
2010 Mar 1
Caimi PF, Barr PM, Berger NA, Lazarus HM. "Non-Hodgkin's lymphoma in the elderly." Drugs & aging. 2010 Mar 1; 27(3):211-38.
2010 Mar
Kaplan D, Meyerson HJ, Li X, Drasny C, Liu F, Costaldi M, Barr P, Lazarus HM. "Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL." Cytometry. Part B, Clinical cytometry. 2010 Mar; 78(2):115-22.
2009 Oct
Barr PM, Fu P, Lazarus HM, Horvath N, Gerson SL, Koc ON, Bahlis NJ, Snell MR, Dowlati A, Cooper BW. "Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma." British journal of haematology. 2009 Oct; 147(1):89-96. Epub 2009 Jun 29.
2009 Aug
Barr PM, Lazarus HM, Cooper BW, Schluchter MD, Panneerselvam A, Jacobberger JW, Hsu JW, Janakiraman N, Simic A, Dowlati A, Remick SC. "Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant." American journal of hematology. 2009 Aug; 84(8):484-7.
2009 Jun
Rong YP, Barr P, Yee VC, Distelhorst CW. "Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor." Biochimica et biophysica acta. 2009 Jun; 1793(6):971-8. Epub 2008 Nov 12.
2008 Sep
Barr PM, Lazarus HM. "Follicular non-Hodgkin lymphoma: long-term results of stem-cell transplantation." Current opinion in oncology. 2008 Sep; 20(5):502-8.
2007 Oct
Barr P, Fu P, Lazarus H, Kane D, Meyerson H, Hartman P, Reyes R, Creger R, Stear K, Laughlin M, Tse W, Cooper B. "Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia." Leukemia & lymphoma. 2007 Oct; 48(10):1940-9.
Barr P, Fisher R, Friedberg J. "The role of bortezomib in the treatment of lymphoma." Cancer investigation. 2007 25(8):766-75.
1997 Jul 18
Malinowski MN, Cannady SB, Schmit KV, Barr PM, Schrock JW, Wilson DF. "Adenosine depresses transmitter release but is not the basis for 'tetanic fade' at the neuromuscular junction of the rat." Neuroscience letters. 1997 Jul 18; 230(2):81-4.
Barr PM, Zent CS. "The ABC of chronic lymphocytic leukemia: Etiology of cytopenias is important in staging and management". Leukemia Lymphoma [EPub in press]. .


Barr PM and Friedberg JW. "Rare B Cell Lymphoproliferative Disorders". Textbook of Uncommon Cancers. Oxford, England: Wiley-Blackwell, 2012.
Barr PM, Creger RJ, Berger NA. "Pharmacology of Acute Lymphoblastic Leukemia Therapy". Adult Acute Lymphocytic Leukemia: Biology and Treatment. : Humana Press, 2010.